Mangoceuticals Inc banner
M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 0.4717 USD -7.49% Market Closed
Market Cap: $8m

Mangoceuticals Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mangoceuticals Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
M
Mangoceuticals Inc
NASDAQ:MGRX
Depreciation & Amortization
$1.7m
CAGR 3-Years
662%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Walgreens Boots Alliance Inc
NASDAQ:WBA
Depreciation & Amortization
$2.4B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
4%
No Stocks Found

Mangoceuticals Inc
Glance View

Market Cap
8m USD
Industry
Retail

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

MGRX Intrinsic Value
0.0319 USD
Overvaluation 93%
Intrinsic Value
Price $0.4717
M

See Also

What is Mangoceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
1.7m USD

Based on the financial report for Dec 31, 2025, Mangoceuticals Inc's Depreciation & Amortization amounts to 1.7m USD.

What is Mangoceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
662%

Over the last year, the Depreciation & Amortization growth was 136%. The average annual Depreciation & Amortization growth rates for Mangoceuticals Inc have been 662% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett